Branchpoint Biosciences
Empowering Microbiome Discovery With Quantitative Precision!
Branchpoint Biosciences is redefining microbiome profiling with qMA™ technology: state-of-the-art quantitative Microbial Assays delivering rapid, precise, and affordable quantification of microorganisms. We empower researchers and clinicians to accelerate discovery and delve deeper into microbiome composition and function. Our diverse range of advanced qPCR products and services are designed to transform microbiome research and unlock new possibilities for innovation.
Request a demo of our qMA™ solutions and transform your research.
Current Product Offerings
qMA™ - quantitative Microbial Assays
Lab validated species-specific qPCR assays (forward and reverse primers and fluorogenic probe) for quantitative detection. Compatible with all commercial real-time PCR machines. Over 120+ validated microbial species currently available, with more under development. Request a species here.
Enhance Your Research with qMA™ Technology
Ready to transform your microbiome research? Contact us today to learn how qMA™ technology can accelerate your discoveries and provide unparalleled insights into microbial communities.
Custom qPCR Design
Custom qPCR assay (primers and fluorogenic probe) design that can be tailored to a desired level of phylogenetic resolution for a specific target. Our standard custom design offering provides species-level resolution...
Products in Development (Coming 2025)
Our products offer quantitative microbiome profiling (qMP™) of the most prevalent bacterial and archaeal species in the human gut, oral cavity, female urinary tract, and vaginal microbiomes. Each product targets of hundreds species - providing a simple, clean, exact, straightforward taxonomic profile without requiring downstream bioinformatics or massive data storage.
- qMP.Oral™
- qMP.UrinaryTract™ (2026)
- qMP.Vaginal™ (2026)
Leadership Team
DR. BENJAMIN TULLY
Co-Founder CEO
Joint-appointment Adjunct Assistant Professor, University of Southern California. Background in bioinformatic infrastructure and microbial genomics.
DR. CHRISTOPHER CORZETT
Co-Founder CSO
Joint-appointment Senior Research Associate, University of Southern California. Background in molecular biology and microbial evolution.
DR. STEVEN FINKEL
Co-Founder Chairman
Joint-appointment Professor Biological Sciences, University of Southern California.
Partners & Collaborators
Branchpoint Biosciences is on a mission to accelerate insights by delivering accurate qPCR-based microbiome profiling. We know that microbiome profiling is not one size fits all. We consider profiling products at three scales: large, multiplexed panels with hundreds of targets; kits consisting of a few to dozens of microorganisms that meet specific market needs; and custom assays to track strains. Branchpoint Bioscience’s qPCR-based technology will transform the way researchers and clinicians profile microbiomes.
Custom qPCR Design Clients
Interested in custom qPCR design? Find out more about our process and how you might implement qPCR in your product design, research, and/or quality control protocols. Contact us for a copy of our white paper. For Procter & Gamble, we designed custom TaqMan qPCR assays to detect Cutibacterium acnes, Staphylococcus capitis, and Staphylococcus epidermidis.